Aeolus Pharmaceuticals Inc. filed its 10-K on Dec 22, 2014 for the period ending Sep 30, 2014. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 152 | |
+0.54% | 42.86B | |
+12.09% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.82% | 25.15B | |
-23.81% | 18.63B | |
+28.22% | 12.37B | |
-3.61% | 11.92B | |
+7.00% | 11.21B |
- Stock Market
- Equities
- AOLS Stock
- News Aeolus Pharmaceuticals, Inc.
- Aeolus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt